why choose us

First received: June 01, 2023

Clinical Trial: CMOP Regimen and Chidamide in the Treatment of Newly Diagnosed Peripheral T-cell Lymphoma

Study Status: Completed

Recruit Status: RECRUITING

Condition: Newly Diagnosed Peripheral T-cell Lymphoma

Study Type: INTERVENTIONAL


Official Title: A Prospective, Single-arm, Multicenter Clinical Study of the Combination of CMOP Regimen and Chidamide in the Treatment of Newly Diagnosed Peripheral T-cell Lymphoma

Brief Summary: Peripheral T-cell lymphoma (PTCL) is a highly heterogeneous and aggressive non-Hodgkin's lymphoma.The incidence rate of PTCL in China is much higher than the global average, and there is no unified standard treatment for initial PTCL.Currently, the CHOP regimen is widely used as first-line treatment.However, the overall response rate is still low, and effective therapies need to be explored.Epigenetics and genetics jointly determine critical features of tumors, and exploring new treatment strategies and…

Read more